Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-875 in type 2 diabetes mellitus
NCT01007097Phase 2Completed
- Sponsor
- Takeda
- Start
- Dec 2009
- Primary completion
- Sep 2010
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial of fasiglifam in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Started Dec 2009; status: completed.
02
Drugs
fasiglifam
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01007097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01007097.